Exit Strategies in Cross-Border Tax Planning: Capital Gains Tax Planning for Selling Cross-Border Businesses

The decision by a Hong Kong family office or mid-cap CFO to exit a cross-border business is no longer a purely commercial calculation. The OECD’s Pillar Two global minimum tax rules, effective for fiscal years beginning on or after 31 December 2023 for many jurisdictions, have fundamentally altered the tax economics of holding companies in low-tax jurisdictions like the British Virgin Islands and the Cayman Islands. Simultaneously, the Inland Revenue Department (IRD) has sharpened its focus on economic substance and residency for Hong Kong-incorporated entities, particularly those with substantial operations in Mainland China. For the US citizen or Green Card holder resident in Hong Kong, the 2025-2026 US tax cycle brings renewed scrutiny on exit transactions under IRC § 877A, with the IRS expanding its examination of expatriation and deemed sales of appreciated assets. This convergence of treaty-based planning, domestic anti-avoidance rules, and global minimum tax regimes makes a structured, multi-layered exit strategy—covering personal, trust, and corporate tiers—a prerequisite for preserving wealth, not merely an optimisation exercise.

The Corporate Layer: Structuring the Sale of a Hong Kong Holding Company with Mainland China Subsidiaries

The operative tax position for a Hong Kong company selling shares in a Mainland China subsidiary is that capital gains are generally exempt from Hong Kong profits tax, provided the gain is not derived from a trade, profession, or business carried on in Hong Kong. This is grounded in the territorial source principle of the Inland Revenue Ordinance (Cap. 112), s. 14. The IRD’s Departmental Interpretation and Practice Notes (DIPN) No. 21 (Revised) establishes that gains from the disposal of capital assets are not taxable unless the taxpayer is a trader in securities. For a mid-cap CFO, the critical distinction lies in whether the Hong Kong holding company is classified as a “trader” in shares—a determination the IRD makes by examining the frequency of transactions, the holding period, and the purpose of acquisition. A single, one-off disposal of a controlling stake in a subsidiary is almost always capital in nature, falling outside the profits tax net.

The China Tax Withholding Trap: Article 13 of the US-China Tax Treaty and the PRC Enterprise Income Tax

When the underlying asset is a Mainland China resident enterprise, the seller must navigate the PRC Enterprise Income Tax (EIT) Law. Under EIT Law, Article 3, a non-resident enterprise that transfers equity in a PRC resident enterprise is subject to a 10% withholding tax on the gain, unless a tax treaty reduces this rate. The US-China Tax Treaty, Article 13 (Capital Gains), provides that gains derived by a resident of one Contracting State from the alienation of shares in a company resident in the other State may be taxed in that other State. However, the treaty does not provide a blanket exemption. The rate reduction to 0% is only available if the seller is a Hong Kong tax resident company that meets the “beneficial ownership” test under the PRC-HK Double Tax Arrangement (DTA) and the PRC’s Circular 601 (2013) requirements. For a US-China treaty context, the US resident seller must demonstrate that the shares are not effectively connected with a permanent establishment in China. The practical risk for a Hong Kong holding company is that the IRD may not issue a Certificate of Resident Status (COR) if the company lacks sufficient economic substance in Hong Kong, thereby exposing the seller to the full 10% PRC withholding tax on the gross gain.

Exit Route: The BVI Holding Company and the Cayman Islands Economic Substance Regime

For structures using a BVI or Cayman Islands holding company, the exit strategy must account for the International Tax Authority (ITA) in the BVI and the Cayman Islands’ International Tax Co-operation (Economic Substance) Act. Under the BVI Business Companies Act (Cap. 213) and the Economic Substance (Companies and Limited Partnerships) Act, 2018, a holding company is a “relevant entity” that must satisfy economic substance tests if it is tax resident in the BVI. However, the ITA’s guidance explicitly states that a pure equity holding company is subject to reduced substance requirements—it must only comply with its statutory obligations under the BVI Business Companies Act. The operative tax position is that if the BVI company is tax resident in Hong Kong (via central management and control), it is exempt from BVI economic substance requirements. For a sale, the seller should ensure that the BVI company’s board meetings and strategic decisions are documented in Hong Kong, with minutes signed by Hong Kong-resident directors. Failure to do so can trigger a penalty of up to USD 75,000 per annum under the BVI Economic Substance Act.

The Individual Layer: US Taxpayers and the Exit Tax Under IRC § 877A

For a US citizen or long-term resident (Green Card holder) living in Hong Kong, the decision to sell a cross-border business may trigger an unexpected and punitive tax liability under IRC § 877A, the expatriation tax. The operative position is that any individual who relinquishes US citizenship or terminates long-term residency and has a net worth exceeding USD 2 million on the date of expatriation, or an average annual net income tax liability exceeding USD 201,000 (2025 figure, inflation-adjusted), is subject to a deemed sale of all worldwide assets as if sold for fair market value on the day before expatriation. This includes the unrealised gain on the shares of the Hong Kong holding company, the BVI entity, and any personal property held in trust.

Interaction with the US-HK Tax Information Exchange Agreement and IRS Examination Cycles

The US-HK Tax Information Exchange Agreement (TIEA), signed in 2014 and effective from 2015, allows the IRS to request information from the IRD on US taxpayers residing in Hong Kong. The IRS examination cycle for high-net-worth individuals (those with assets over USD 10 million) has been steadily increasing, with the Large Business and International (LB&I) division targeting taxpayers with foreign corporations, partnerships, and trusts. For a US citizen selling a Hong Kong business, the IRS will closely scrutinise the valuation of the business and the allocation of the purchase price between goodwill, tangible assets, and the underlying shares. Under IRC § 351, a transfer of assets to a controlled foreign corporation (CFC) in exchange for stock is generally tax-free, but the subsequent sale of that stock is subject to IRC § 1248, which recharacterises part of the gain as a dividend to the extent of the CFC’s accumulated earnings and profits. The 2025-2026 IRS Priority Guidance Plan explicitly lists guidance on the application of IRC § 877A to trusts, making this a live issue for family offices.

The FBAR and FATCA Compliance Trap on Exit

A US taxpayer who expatriates or sells a cross-border business must file a final FBAR (FinCEN Form 114) and FATCA Form 8938 for the year of the transaction. The threshold for Form 8938 is USD 200,000 in specified foreign financial assets for a taxpayer living abroad. The failure to file these forms can result in penalties of up to 50% of the value of the unreported account or asset. For a Hong Kong trust holding the business, the US taxpayer must also file Form 3520 (Annual Return to Report Transactions With Foreign Trusts) and Form 3520-A (Annual Information Return of Foreign Trust With a US Owner). The IRS has a six-year statute of limitations under IRC § 6501(e) for omissions exceeding 25% of gross income, which is extended to a permanent statute in cases of fraud. The operative risk is that a missed filing during the exit year can open a multi-year examination window.

The Trust Layer: Preserving Wealth Through a BVI Trust or Hong Kong Trust

The operative tax position for a Hong Kong family office is that a properly structured irrevocable trust can shield the sale proceeds from the settlor’s estate for US estate tax purposes (IRC § 2036 and § 2038) and from Hong Kong stamp duty on the transfer of Hong Kong-listed shares. For a US settlor, the trust must be a “foreign trust” under IRC § 7701(a)(31), meaning a court within the United States does not have primary supervision over its administration, and one or more US persons do not have the authority to control all substantial decisions. A Hong Kong trust administered by a licensed trust company under the Hong Kong Trustee Ordinance (Cap. 29) qualifies as a foreign trust.

The Grantor Trust Trap: IRC § 679 and the Sale of Business Shares

A US citizen settlor who transfers shares of a cross-border business to a foreign trust with a US beneficiary is treated as the owner of the trust under IRC § 679. This means the trust is a grantor trust, and all income, including the capital gain from the sale of the business shares, is taxable directly to the settlor on their US tax return. The trap is that a sale of the business by the trust before the settlor’s death will be taxed at the settlor’s individual capital gains rate (currently 23.8% including the Net Investment Income Tax under IRC § 1411), rather than at the trust’s compressed rates. To avoid this, the trust must be structured as a non-grantor trust with no US beneficiaries or with a power of appointment that defers the US tax liability until distributions are made. For a Hong Kong family, the standard structure is a non-grantor trust with a Hong Kong-resident trustee and a BVI company as the holding entity for the operating business.

The Cayman Islands STAR Trust and the BVI VISTA Trust

For UHNW families, the Cayman Islands STAR (Special Trusts Alternative Regime) Trust and the BVI VISTA (Virgin Islands Special Trusts Act) Trust offer specific advantages for holding business shares. A VISTA Trust, under the BVI Virgin Islands Special Trusts Act, 2003 (as amended), allows the settlor to retain control over the management of the underlying BVI company’s shares without the trustee’s intervention. This is critical for a family business sale, as the trustee cannot be compelled to sell the shares against the wishes of the “designated person” (usually a family member). The operative tax position for a US taxpayer is that a VISTA Trust is still a grantor trust under IRC § 679 if a US person is a beneficiary, so the trust must be carefully drafted to avoid US beneficiary status during the settlor’s lifetime. A STAR Trust, by contrast, can have non-charitable purposes (e.g., “to hold the family business for future generations”) without identifiable beneficiaries, which can avoid the grantor trust rules entirely for US tax purposes.

The Treaty Layer: Optimising the Exit Route Through the US-China Tax Treaty and the PRC-HK DTA

The operative tax position for a Hong Kong resident selling shares in a Mainland China company is that the capital gain is taxable only in Hong Kong under the PRC-HK DTA, Article 13(4), provided the seller is a “resident of Hong Kong” under Article 4 of the DTA. The definition of “resident” in Article 4 requires that the person is liable to tax in Hong Kong by reason of domicile, residence, place of management, or any other criterion of a similar nature. For a Hong Kong company, this means it must be subject to profits tax on its worldwide income, even if it claims a territorial exemption. The IRD’s practice is to issue a COR only if the company has a physical office, employees, and board meetings in Hong Kong. For a US citizen selling through a Hong Kong company, the US-China Tax Treaty, Article 13, does not provide a specific exemption for gains from the sale of shares in a Chinese company by a Hong Kong resident. Instead, the US citizen must rely on the saving clause (Article 1, paragraph 3) which preserves the right of the United States to tax its citizens as if the treaty had not come into effect. This means the US citizen is still subject to US tax on the gain, but may claim a foreign tax credit for any PRC withholding tax paid.

The Principal Purpose Test (PPT) Under the MLI

The Multilateral Instrument (MLI), which the PRC and Hong Kong have both signed, introduces a Principal Purpose Test (PPT) under Article 7 of the MLI. The PPT denies treaty benefits if obtaining that benefit was one of the principal purposes of the arrangement or transaction. For a Hong Kong holding company that was recently incorporated or that has no economic substance, the IRD or the Chinese tax authorities may deny the capital gains exemption under the PRC-HK DTA. The 2025-2026 tax cycle has seen the Chinese State Taxation Administration (STA) increasingly applying the PPT to deny treaty benefits for Hong Kong companies that cannot demonstrate a genuine business purpose. The operative risk is that a sale structured through a Hong Kong company with minimal substance will be recharacterised as a direct sale by the ultimate beneficial owner, triggering the full 10% PRC withholding tax plus penalties and interest under the PRC Tax Collection and Administration Law.

Exit Strategy: The Double Irish and the Singapore-HK Treaty Alternative

For a mid-cap CFO with operations in multiple jurisdictions, the traditional “Double Irish” structure (an Irish company holding a BVI company that holds a Hong Kong company) has been effectively closed by the OECD’s BEPS Action 5 and the Irish Finance Act 2020. The alternative is a Singapore-Hong Kong treaty structure. Under the Singapore-HK DTA, Article 13(4), gains from the alienation of shares in a company resident in one Contracting State are taxable only in that State if the shares derive more than 50% of their value from immovable property situated in that State. For a technology or services company without significant real estate, the gain is taxable only in the seller’s country of residence. A Singapore resident company selling shares in a Hong Kong operating company would therefore pay no Hong Kong profits tax on the gain, and Singapore does not tax capital gains. The practical requirement is that the Singapore company must have genuine economic substance in Singapore, including a physical office, at least two resident directors, and audited financial statements filed with the Accounting and Corporate Regulatory Authority (ACRA).

Actionable Takeaways

1. Before any sale, confirm the Hong Kong holding company’s tax residence by obtaining a Certificate of Resident Status from the IRD, and ensure the company has a physical office and board meetings in Hong Kong to satisfy the PRC-HK DTA’s beneficial ownership test.
2. For a US citizen or Green Card holder, file a final FBAR and FATCA Form 8938 for the year of the sale, and consider a pre-exit tax planning review under IRC § 877A to determine whether expatriation is advisable before the transaction.
3. Structure the sale through a non-grantor foreign trust (e.g., a Cayman Islands STAR Trust) to avoid immediate US taxation on the gain and to shield the proceeds from US estate tax.
4. For a Mainland China subsidiary, ensure the Hong Kong holding company has held the shares for at least 12 months and has not derived more than 50% of its value from PRC immovable property to qualify for the capital gains exemption under the PRC-HK DTA, Article 13.
5. Engage a licensed tax advisor in both Hong Kong and the United States at least six months before the planned exit to document economic substance and to prepare the necessary treaty relief claims and IRS forms.

---

本文不構成稅務建議。涉及個人稅務情況請諮詢持牌會計師或稅務師。 This does not constitute tax advice. Consult a licensed CPA or tax advisor for your specific situation.